Table 2. Cox regression.
(A) Cox-regression analysis of time to progression. (B) Cox-regression analysis of overall survival.
| Clinicopathological variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | |
| (A) Cox-regression analysis of time to progression | ||||
| Sex | 2.679 (1.154–6.223) | 0.022 | 2.861 (1.210–6.762) | 0.017 |
| Age | 0.964 (0.941–0.988) | 0.004 | 0.961 (0.937–0.985) | 0.002 |
| Tumor size | 1.061 (1.008–1.115) | 0.022 | 1.063 (1.008–1.121) | 0.025 |
| Tumor number | 1.088 (0.701–1.689) | 0.707 | ||
| Cirrhosis status | 0.909 (0.678–1.218) | 0.522 | ||
| Differentiation status | 0.770 (0.541–1.097) | 0.770 | ||
| DAPK1 staining status | 0.486 (0.299 = 0.790) | 0.004 | 0.479 (0.291–0.791) | 0.004 |
| (B) Cox-regression analysis of overall survival | ||||
| Sex | 1.400 (0.721–2.722) | 0.320 | ||
| Age | 0.969 (0.948–0.992) | 0.007 | 0.976 (0.954–0.997) | 0.027 |
| Tumor size | 1.077 (1.029–1.128) | 0.001 | 1.077 (1.030–1.127) | 0.001 |
| Tumor number | 1.021 (0.644–1.618) | 0.931 | ||
| Cirrhosis status | 0.841 (0.636–1.113) | 0.227 | ||
| Differentiation status | 0.675 (0.484–0.941) | 0.021 | ||
| DAPK1 staining status | 0.597 (0.382–0.932) | 0.023 | 0.604 (0.384–0.951) | 0.030 |